Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Am Fam Physician ; 102(10): 613-621, 2020 11 15.
Article in English | MEDLINE | ID: mdl-33179891

ABSTRACT

Drugs are being prescribed with more frequency and in higher quantities. A serious adverse drug event from prescribed medications constitutes 2.4% to 16.2% of all hospital admissions. Many of the adverse drug events present intraorally or periorally in isolation or as a clinical symptom of a systemic effect. Clinical recognition and treatment of adverse drug events are important to increase patient adherence, manage drug therapy, or detect early signs of potentially serious outcomes. Oral manifestations of commonly prescribed medications include gingival enlargement, oral hyperpigmentation, oral hypersensitivity reaction, medication-related osteonecrosis, xerostomia, and other oral or perioral conditions. To prevent dose-dependent adverse drug reactions, physicians should prescribe medications judiciously using the lowest effective dose with minimal duration. Alternatively, for oral hypersensitivity reactions that are not dose dependent, quick recognition of clinical symptoms associated with time-dependent drug onset can allow for immediate discontinuation of the medication without discontinuation of other medications. Physicians can manage oral adverse drug events in the office through oral hygiene instructions for gingival enlargement, medication discontinuation for oral pigmentation, and prescription of higher fluoride toothpastes for xerostomia.


Subject(s)
Antihypertensive Agents/adverse effects , Drug Hypersensitivity/etiology , Gingival Overgrowth/chemically induced , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Hyperpigmentation/chemically induced , Hypoglycemic Agents/adverse effects , Xerostomia/chemically induced , Albuterol/adverse effects , Amlodipine/adverse effects , Anticonvulsants/adverse effects , Atorvastatin/adverse effects , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Bronchodilator Agents/adverse effects , Deprescriptions , Fluorides/therapeutic use , Gingival Overgrowth/therapy , Humans , Hyperpigmentation/therapy , Lisinopril/adverse effects , Losartan/adverse effects , Metformin/adverse effects , Metoprolol/adverse effects , Mouth Diseases/chemically induced , Mouth Diseases/therapy , Omeprazole/adverse effects , Oral Hygiene , Proton Pump Inhibitors/adverse effects , Simvastatin/adverse effects , Thyroxine/adverse effects , Toothpastes/therapeutic use , Xerostomia/therapy
SELECTION OF CITATIONS
SEARCH DETAIL